SEARCH

SEARCH BY CITATION

References

  • 1
    Weiner H. Oral tolerance. Proc Natl Acad Sci U S A 1994; 91:1076210765.MEDLINE
  • 2
    Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997; 18:335343.MEDLINE
  • 3
    Miller A, Lider O, Roberts AB, Sporn M, Weiner HL. Suppressor T cells generated by oral tolerance to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGFβ following antigen specific triggering. Proc Natl Acad Sci U S A 1992; 89:421425.MEDLINE
  • 4
    Crispe N, Mehal WZ. Strange brew: T cells in the liver. Immun Today 1996; 11:236245.
  • 5
    Ilan Y, Roy Chowdhury N, Sauter B, Thummala NR, Horwitz MS, Davidson A, Nakamura J, et al. A critical role of the liver in inducing oral tolerance to adenoviral vectors for long term gene therapy. Gastro 114:236245.
  • 6
    Callery MP, Kamei T, Flye W. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J Surg Res 1989; 46:391394.MEDLINE
  • 7
    Nakano Y, Monden M, Valdivia LA, Gotoh M, Tono T, Mori T. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats. Surgery 1992; 111:668676.MEDLINE
  • 8
    Yu SY, Nakafusa Y, Flye MW. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsivenss and graft tolerance. Surgery 1994; 116:229234.MEDLINE
  • 9
    Garcia-Barcina M, Winnock M, Bidaurrazaga I, Huet S, Biolac Sage P, Balabaud C. Detection of cell adhesions molecules on human liver associated lymphocytes. Immunology 1994; 82:958.MEDLINE
  • 10
    MacDonaland RH. NK1.1+ T cells receptor a/b + cells: new clues to their origin, specificity and function. J Exp Med 1995; 182:633638.MEDLINE
  • 11
    Bendelac A. Mouse NK1.1+ T cells. Curr Opin in Immunol 1995; 7:367374.
  • 12
    Takahashi M, Ogasawara K, Takeda K, Hashimoto W, Sakihara H, Kumagai K, Anzai R. LPS induces NK1. 1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol 1996; 156:24362442.MEDLINE
  • 13
    Doherty DG, Norris S, Collins C, McEntee G, Traynor O, Hegarty J, O'Farrelly C. Human lymphocytes with dual T cell and natural killer cell phenotype and function in the normal adult liver. Hepatology 26:24362442.
  • 14
    Neurath M, Kelasall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGFβ-mediated oral tolerance. J Exp Med 1996; 183:26052616.MEDLINE
  • 15
    Mizoguchi A, Mizoguchi E, Chiba C, Spiekermann GM, Tonegawa S, Anderson CN, Bhan AK. Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 1996; 183:847856.MEDLINE
  • 16
    Strober W, Kelsall B, Fuss L, Marth T, Ludviksson B, Ehrhardt R, Neurath M. Reciprocal IFN-γ and TGF β responses regulate the occurrence of mucosal inflammation. Immunol Today 1997; 18:6164.MEDLINE
  • 17
    Ilan Y, Weksler-Zangen S, Ben-Horin S, Sestiere M, Diment J, Sauter B, Roy Chowdhury N, et al. Treatment of experimental colitis through induction of oral tolerance towards colitis extracted proteins. Gastroenterology 114:6164.
  • 18
    Ilan Y, Sauter B, Roy Chowdhury N, Prakash R, Reddy BVN, Sengupta K, Horwitz MS, et al. Effective adenovirus-mediated gene therapy in the presence of preexisting anti-adenovirus antibodies by oral tolerization of the host. Hepatology 1998; 27:13681376.MEDLINE
  • 19
    Koo GC, Dumont FJ, Tutt M, Hackett J, Kumar V. The NK1.1-mouse: A model to study differentiation of murine NK cells. J Immunol 1988; 137:37423747.
  • 20
    Ilan Y, Prakash R, Jona VK, Sengupta K, Davidson A, Horwitz M, Roy Chowdhury N, et al. Adoptive transfer of tolerance from rats tolerized to adenoviral antigens allows long term adenovirus-mediated gene therapy in Gunn rats. Hepatology 24:37423747.
  • 21
    Kawamura T, Takeda K, Mendiratta SK, Kawamura H, Van Kaer L, Tagita H, Abo T, et al. Critical role of NK1+ T cells in IL12 induced immune response in vivo. J immunol 1998; 160:1619.MEDLINE
  • 22
    Ilan Y, Prakash R, Davidson A, Jona VK, Droguett G, Horwitz MS, Roy Chowdhury N, et al. Oral tolerization to adenoviral antigens permits long term gene expression using recombinant adenoviral vectors. J Clin Invest 1997; 99:10981106.MEDLINE
  • 23
    Takahashi M, Ilan Y, Sengupta K, Roy Chowdhury N, Roy Chowdhury J. Induction of tolerance to recombinant adenoviruses by injection into newborn rats: Long term amelioration of hyperbilirubinemia in Gunn rats. J Biol Chem 1996; 271:2653626542.MEDLINE
  • 24
    Ilan Y, Jona VK, Sengupta K, Davidson A, Horwitz MS, Roy Chowdhury N, Roy Chowdhury J. Transient immunosuppression with FK506 permits long term expression of therapeutic genes introduced into the liver using recombinant adenoviruses. Hepatology 1997; 26:949956.MEDLINE
  • 25
    Ilan Y, Droguett G, Roy Chowdhury N, Yongan L, Sengupta K, Thummala NR, Davidson A, et al. Insertion of the Adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long term gene expression. Proc Natl Acad Sci U S A 1997; 94:25872592.MEDLINE
  • 26
    Ilan Y, Attavar P, Takahashi M, Davidson A, Horwitz M, Guida J, Roy Chowdhury N, Roy Chowdhury J. Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long term gene therapy in Gunn rats. J Clin Invest 1996; 98:26402647.MEDLINE
  • 27
    Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA. Double-blind pilot trial of oral tolerization with myelin antigen in multiple sclerosis. Science 1993; 261:13211324.MEDLINE
  • 28
    Peng HJ, Chang ZN, Han SH, Won MH, Huang BT. Chemical denaturation of ovalbumin abrogates the induction of oral tolerance of specific IgG antibody and DTH response in mice. Scand J Immunol 1995; 42:297304.MEDLINE
  • 29
    Carvalho BA, Verdolin SA, Vaz NM. Indirect effects of oral tolerance cannot be ascribed to bystander suppression. Scand J Immunol 1997; 45:276281.MEDLINE
  • 30
    Blanas E, Carbone FR, Allison J, Miller JA, Heath WR. Induction of autoimmune diabetes by oral administration of autoantigen. Science 1996; 274:17071709.MEDLINE
  • 31
    Christian K, Hiroshi K, Carbone FR, Jacques AP, Miller JF, Heath WR. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8+T cells. J Exp Med 1997; 186:239245.MEDLINE
  • 32
    Bennett SRM, Carbone FR, Karamalis F, Miller JF, Heath WR. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 1997; 186:6570.MEDLINE
  • 33
    Mestscky J, Abraham R, Ogra PL. Common mucosal immune system and strategies for the development of vaccines effective at the mucosa surfaces. In: OrgaPL, MesteckyJ, LammME, eds. Mucosal Immunology. San Diego, CA: Academic Press, 1994;357372.
  • 34
    Marth T, Strober W, Kelsall BL. High dose oral tolerance in ovalbumin TCR-Transgenic mice. J Immunol 1996; 157:23482357.MEDLINE
  • 35
    Van Deventer Sander J, Charles O, Fedorak RN. Multiple doses of intravenous interleukin 10 in steroid refractory Crohn's disease. Gastroenterology 1997; 113:383389.MEDLINE
  • 36
    Hisama N, Yamaguchi Y, Ishiko T, Miyanari N, Ichiguchi O, Goto M, Mori K, et al. Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology 1996;11931198.
  • 37
    Shi J, Fujieda H, Kokubo Y, Wake K. Apoptosis of neutrophils and their elimination by Kupffer cells in rat liver. Hepatology 1996; 24:12561263.MEDLINE
  • 38
    Collins C, Norris S, McEntee G, Traynor O, Bruno L, Von Boehmer H, Hegarty J, et al. RAG1, RAG2 and pre-T cell receptor α chain expression by adult human hepatic T cells: evidence for extrathymic T cell maturation. Eur J Immunol 1996; 26:31143118.MEDLINE
  • 39
    Tsukahara A, Seki S, Liai T, Moroda T, Watanabe H, Suzuki S, Tada T, et al. Mouse liver T cells: Their change with aging and in comparison with peripheral T cells. Hepatology 1997; 26:301311.MEDLINE
  • 40
    Schultz RJ, Parkes A, Mizoguchu E, Bhan AK, Koyasu S. Development of CD4- CD8- ab TCR+NK1.1+ lymphocytes. J Immunol 1996; 157:43794389.MEDLINE
  • 41
    Enomoto A, Nishimura H, Yoshikai Y. Predominant appearance of NK1.1+ T cells producing IL4 may be involved in the increased susceptibility of mice with the Beige mutation during Salmonella infection. J Immunol 1997; 158:22682277.MEDLINE
  • 42
    Brown DR, Fowell DJ, Corry DB, Wynn TA, Moskowitz NH, Cheever AW, Locksley RM, et al. β2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell immune responses. J Exp Med 1996; 184:12951304.MEDLINE
  • 43
    Dohert DG, Norris S, Collins C, McEntee G, Traynor O, Hegarty J, O'Farrelly C. Distinct cytotoxic lymphocytes subsets suggest a role for the liver in immune homeostasis. J Hepatology 1998; 28:59A.
  • 44
    Jonsson JR, Edwards-Smith CJ, Morotomi Y, Hogan PG, Clouston AD, Lynch SV, Strong RW, et al. Expression of Fas/FasL and bcl2 in normal human liver derived leukocytes. Hepatology 1997; 26:269A.